Human Molecular Genetics, 2000, Vol. 9, No. 13 1987-1994
© 2000 Oxford University Press
Molecular effects of calcium binding mutations in Marfan syndrome depend on domain context
Department of Biochemistry and 1MRC Immunochemistry Unit, University of Oxford, South Parks Road, Oxford OX1 3QU, UK
Mutations in the human fibrillin-1 (FBN-1) gene cause Marfan syndrome (MFS), an autosomal dominant disease of connective tissue. Fibrillin-1, a 350 kDa extracellular calcium binding protein, is a major structural component of 1012 nm microfibrils and consists predominantly of two repeated module types: the calcium binding epidermal growth factor-like (cbEGF) domain and the transforming growth factor ß1 binding protein-like (TB) domain. A group of reported FBN-1 mutations is predicted to reduce calcium binding to cbEGF domains by removal of a side chain ligand for calcium. These mutations occur in two protein domain contexts, either in a cbEGF preceded by a TB domain or in a cbEGF preceded by another cbEGF domain. In this study we have used three proteases to probe structural changes caused by an N2144S MFS calcium binding mutation in a TB6cbEGF32 and a cbEGF3233 domain pair, and an N2183S mutation in the cbEGF3233 pair. N-terminal sequence analysis of domain pairs digested in the presence and absence of calcium show that: (i) domain interactions between TB6 and cbEGF32 are calcium independent, despite the presence of a calcium binding site in cbEGF32; (ii) domain interactions between cbEGF32 and cbEGF33 are calcium dependent; and (iii) an N
S mutation causes increased proteolytic susceptibility only when located in cbEGF33, consistent with a key role for interdomain calcium binding in rigidifying cbEGF domain linkages. These data demonstrate for the first time that the structural consequences of calcium binding mutations in fibrillin-1 cbEGF domains can be influenced by domain context.
+ To whom correspondence should be addressed. Tel: +44 1865 285347; Fax: +44 1865 275259; Email: penny@bioch.ox.ac.uk
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
J. Cordle, C. RedfieldZ, M. Stacey, P. A. van der Merwe, A. C. Willis, B. R. Champion, S. Hambleton, and P. A. Handford Localization of the Delta-like-1-binding Site in Human Notch-1 and Its Modulation by Calcium Affinity J. Biol. Chem., April 25, 2008; 283(17): 11785 - 11793. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. M. Abbott, I. Spendlove, P. Roversi, H. Fitzgibbon, V. Knott, P. Teriete, J. M. McDonnell, P. A. Handford, and S. M. Lea Structural and Functional Characterization of a Novel T Cell Receptor Co-regulatory Protein Complex, CD97-CD55 J. Biol. Chem., July 27, 2007; 282(30): 22023 - 22032. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Whiteman, A. C. Willis, A. Warner, J. Brown, C. Redfield, and P. A. Handford Cellular and molecular studies of Marfan syndrome mutations identify co-operative protein folding in the cbEGF12-13 region of fibrillin-1 Hum. Mol. Genet., April 15, 2007; 16(8): 907 - 918. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Guo, P. Booms, M. Halushka, H. C. Dietz, A. Ney, S. Stricker, J. Hecht, S. Mundlos, and P. N. Robinson Induction of Macrophage Chemotaxis by Aortic Extracts of the mgR Marfan Mouse Model and a GxxPG-Containing Fibrillin-1 Fragment Circulation, October 24, 2006; 114(17): 1855 - 1862. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. T. Mellody, L. J. Freeman, C. Baldock, T. A. Jowitt, V. Siegler, B. D. E. Raynal, S. A. Cain, T. J. Wess, C. A. Shuttleworth, and C. M. Kielty Marfan Syndrome-causing Mutations in Fibrillin-1 Result in Gross Morphological Alterations and Highlight the Structural Importance of the Second Hybrid Domain J. Biol. Chem., October 20, 2006; 281(42): 31854 - 31862. [Abstract] [Full Text] [PDF] |
||||
![]() |
P N Robinson, E Arteaga-Solis, C Baldock, G Collod-Beroud, P Booms, A De Paepe, H C Dietz, G Guo, P A Handford, D P Judge, et al. The molecular genetics of Marfan syndrome and related disorders J. Med. Genet., October 1, 2006; 43(10): 769 - 787. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Hubmacher, K. Tiedemann, R. Bartels, J. Brinckmann, T. Vollbrandt, B. Batge, H. Notbohm, and D. P. Reinhardt Modification of the Structure and Function of Fibrillin-1 by Homocysteine Suggests a Potential Pathogenetic Mechanism in Homocystinuria J. Biol. Chem., October 14, 2005; 280(41): 34946 - 34955. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Y. Suk, S. Jensen, A. McGettrick, A. C. Willis, P. Whiteman, C. Redfield, and P. A. Handford Structural Consequences of Cysteine Substitutions C1977Y and C1977R in Calcium-binding Epidermal Growth Factor-like Domain 30 of Human Fibrillin-1 J. Biol. Chem., December 3, 2004; 279(49): 51258 - 51265. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Vollbrandt, K. Tiedemann, E. El-Hallous, G. Lin, J. Brinckmann, H. John, B. Batge, H. Notbohm, and D. P. Reinhardt Consequences of Cysteine Mutations in Calcium-binding Epidermal Growth Factor Modules of Fibrillin-1 J. Biol. Chem., July 30, 2004; 279(31): 32924 - 32931. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Sabbagh, G. Boileau, M. Campos, A. K. Carmona, and H. S. Tenenhouse Structure and Function of Disease-Causing Missense Mutations in the PHEX Gene J. Clin. Endocrinol. Metab., May 1, 2003; 88(5): 2213 - 2222. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Whiteman and P. A. Handford Defective secretion of recombinant fragments of fibrillin-1: implications of protein misfolding for the pathogenesis of Marfan syndrome and related disorders Hum. Mol. Genet., April 1, 2003; 12(7): 727 - 737. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. S. Smallridge, P. Whiteman, J. M. Werner, I. D. Campbell, P. A. Handford, and A. K. Downing Solution Structure and Dynamics of a Calcium Binding Epidermal Growth Factor-like Domain Pair from the Neonatal Region of Human Fibrillin-1 J. Biol. Chem., March 28, 2003; 278(14): 12199 - 12206. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Chaudhry, J. Gazzard, C. Baldock, J. Dixon, M. J. Rock, G. C. Skinner, K. P. Steel, C. M. Kielty, and M. J. Dixon Mutation of the gene encoding fibrillin-2 results in syndactyly in mice Hum. Mol. Genet., April 1, 2001; 10(8): 835 - 843. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Whiteman, R. S. Smallridge, V. Knott, J. J. Cordle, A. K. Downing, and P. A. Handford A G1127S Change in Calcium-binding Epidermal Growth Factor-like Domain 13 of Human Fibrillin-1 Causes Short Range Conformational Effects J. Biol. Chem., May 11, 2001; 276(20): 17156 - 17162. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-H. Lin, M. Stacey, C. Saxby, V. Knott, Y. Chaudhry, D. Evans, S. Gordon, A. J. McKnight, P. Handford, and S. Lea Molecular Analysis of the Epidermal Growth Factor-like Short Consensus Repeat Domain-mediated Protein-Protein Interactions. DISSECTION OF THE CD97-CD55 COMPLEX J. Biol. Chem., June 22, 2001; 276(26): 24160 - 24169. [Abstract] [Full Text] [PDF] |
||||




